Chloral hydrate for progressive myoclonus epilepsy: A new look at an old drug

Pediatric Neurology

Volumn 25, Issue 5, 2001, Pages 385-389

  Pranzatelli, Michael R ^a   Tate, Elizabeth D ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CHLORAL HYDRATE; CLONAZEPAM; ETIRACETAM; MEPHENYTOIN; PHENYTOIN; PIRACETAM; PRIMIDONE; TOPIRAMATE; VALPROATE SEMISODIUM; ZONISAMIDE;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG CAPSULE; DRUG FORMULATION; DRUG TOLERANCE; ELECTROENCEPHALOGRAM; EXTERNAL OPHTHALMOPLEGIA; FEMALE; HUMAN; MALE; MYOCLONUS EPILEPSY; ONSET AGE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SEDATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHLORAL HYDRATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; EPILEPSIES, MYOCLONIC; FEMALE; HUMANS; LONG-TERM CARE; MALE; OPHTHALMOPLEGIA, CHRONIC PROGRESSIVE EXTERNAL; TREATMENT OUTCOME; UNVERRICHT-LUNDBORG SYNDROME;

EID: 0035670055     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(01)00350-2     Document Type: Article

References (50)

1. The clinical challenge of progressive myoclonus epilepsy
2. High-dose chloral hydrate sedation for children undergoing MR imaging: Safety and efficacy in relation to age
3. Adverse sedation events in pediatrics: Analysis of medications used for sedation
4. Use of chloral hydrate for sedation in children
5. Effect of enterohepatic circulation on the pharmacokinetics of chloral hydrate and its metabolites in F344 rats
6. Metabolism of trichloroethylene
7. Mutagenicity of trichloroethylene and its metabolites: Implications for the risk assessment of trichloroethylene
8. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol
9. The neuropharmacology of progressive myoclonus epilepsy: Response to 5-hydroxy-L-tryptophan
10. Buspirone in progressive myoclonus epilepsy
11. Baltic myoclonus and Crohn's disease
12. Antidyskinetic drug therapy for pediatric movement disorders
13. Chloral hydrate: The good and the bad
14. Absorption, excretion and metabolic fate of chloral hydrate and trichloroethanol
15. Clinical pharmacokinetics of hypnotics
16. Studies on the mutagenic and carcinogenic potential of chloral hydrate
17. Pharmacokinetics of trichloroethanol and metabolites and interconversions among variously referenced pharmacokinetic parameters
18. Comparison of the effects of chloral hydrate and trichloroethanol on the EEG of the isolated perfused rat brain
19. Essential familial myoclonus
20. Antimyoclonic effects of alcohol in progressive myoclonus epilepsy
21. Progressive myoclonic epilepsies syndrome (Ramsay Hunt syndrome) with mental disorder: Report of two cases
22. Action myoclonus (Lance-Adam syndrome) secondary to strangulation with dramatic response to alcohol
23. Beneficial effect of alcohol in hereditary cerebellar ataxia with myoclonus (progressive myoclonic ataxia): Report of two siblings
24. Alcohol-responsive myoclonic dystonia in a large family: Dominant inheritance and phenotypic variation
25. Gamma-hydroxybutyric acid for alcohol-sensitive myoclonus with dystonia
26. General anaesthetics inhibit the responses induced by glutamate receptor agonists in the mouse cortex
27. The actions of ether, alcohol and alkane general anaesthetics on GABA A and glycine receptors and the effects of TM2 and TM3 mutations
28. GABA- and glutamate-gated ion channels as molecular sites of alcohol and anesthetic action
29. 3 receptor-mediated ion current in nodose ganglion neurons from the adult rat
30. Inhibition of excitatory amino acid-activated currents by trichloroethanol and trifluoroethanol in mouse hippocampal neurons
31. Trichloroethanol impairs NMDA receptor function in rat mesencephalic and cortical neurons
32. Inhibition by chloral hydrate and trichloroethanol of AMPA-induced Ca (2+) influx in rat cultured cortical neurons
33. Chloral hydrate and triclofos metabolism
34. Comparative study of the effects of chloral hydrate and trichloroethanol on cerebral metabolism
35. Chloral hydrate: Unusual high concentrations in a fatal overdose
36. Decrease of GABA in the cerebrospinal fluid of patients with progressive myoclonus epilepsy and its correlation with the decrease of 5HIAA and HVA
37. Long-term administration of psychotropic drugs: Effects on human sleep
38. Chloral hydrate: A risky old psychotropic drug
39. Observations on chloralose-induced myoclonus in guinea pigs
40. Effects of a controlled challenge of chloral hydrate in pneumatosis cystoides coli: Further evidence of a causal link?
41. Alkyl halides, super hydrogen production and the pathogenesis of pneumatosis cystoids coli
42. Interindividual variance of cytochrome P450 forms in human hepatic microsomes: Correlation of individual forms with xenobiotic metabolism and implications in risk assessment
43. Cardiac arrhythmia in a child after the usual dose of chloral hydrate
44. Seizures caused by chloral hydrate sedative doses
45. A compilation of LD50 values in newborn and adult animals
46. Carcinogenicity of chloral hydrate administered in drinking water to the male F344/N rat and male B6C3F1 mouse
47. Chloral and chloral hydrate
48. A species comparison of chloral hydrate metabolism in blood and liver
49. Species- and sex-related differences in metabolism of trichloroethylene to yield chloral and trichloroethanol in mouse, rat, and human liver microsomes
50. Biochemical effects of chloral hydrate on male rats following 7-day drinking water exposure